Kristi Anseth
Concepts (678)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydrogels | 153 | 2023 | 596 | 27.160 |
Why?
| Polyethylene Glycols | 114 | 2023 | 560 | 17.870 |
Why?
| Biocompatible Materials | 80 | 2023 | 373 | 12.860 |
Why?
| Extracellular Matrix | 55 | 2023 | 461 | 9.850 |
Why?
| Tissue Engineering | 54 | 2022 | 366 | 8.560 |
Why?
| Cell Culture Techniques | 34 | 2023 | 354 | 7.040 |
Why?
| Myofibroblasts | 16 | 2023 | 132 | 5.820 |
Why?
| Chondrocytes | 24 | 2021 | 216 | 5.600 |
Why?
| Aortic Valve | 23 | 2022 | 428 | 5.390 |
Why?
| Heart Valves | 14 | 2019 | 46 | 5.130 |
Why?
| Polymers | 45 | 2022 | 475 | 5.050 |
Why?
| Sulfhydryl Compounds | 18 | 2020 | 190 | 4.620 |
Why?
| Calcinosis | 11 | 2022 | 292 | 4.400 |
Why?
| Cells, Cultured | 78 | 2023 | 4162 | 4.300 |
Why?
| Organoids | 8 | 2023 | 81 | 4.240 |
Why?
| Mechanotransduction, Cellular | 9 | 2023 | 102 | 3.970 |
Why?
| Cross-Linking Reagents | 32 | 2018 | 190 | 3.840 |
Why?
| Fibroblasts | 18 | 2023 | 846 | 3.760 |
Why?
| Cell Differentiation | 33 | 2022 | 1805 | 3.560 |
Why?
| Osteogenesis | 15 | 2020 | 222 | 3.520 |
Why?
| Elasticity | 17 | 2020 | 192 | 3.440 |
Why?
| Tissue Scaffolds | 17 | 2022 | 195 | 3.400 |
Why?
| Oligopeptides | 18 | 2013 | 255 | 3.360 |
Why?
| Aortic Valve Stenosis | 8 | 2022 | 315 | 3.240 |
Why?
| Click Chemistry | 10 | 2021 | 52 | 3.090 |
Why?
| Swine | 35 | 2022 | 777 | 3.080 |
Why?
| Hydrogel, Polyethylene Glycol Dimethacrylate | 17 | 2016 | 71 | 3.010 |
Why?
| Photochemistry | 32 | 2021 | 137 | 3.000 |
Why?
| Osteoblasts | 13 | 2022 | 119 | 2.920 |
Why?
| Biomimetic Materials | 11 | 2018 | 69 | 2.830 |
Why?
| Cell Survival | 35 | 2019 | 1075 | 2.810 |
Why?
| Light | 22 | 2020 | 346 | 2.560 |
Why?
| Cellular Microenvironment | 7 | 2022 | 82 | 2.560 |
Why?
| Hydrazones | 6 | 2022 | 25 | 2.470 |
Why?
| Animals | 130 | 2023 | 34133 | 2.450 |
Why?
| Peptides | 15 | 2015 | 893 | 2.360 |
Why?
| Photolysis | 9 | 2020 | 81 | 2.320 |
Why?
| Drug Delivery Systems | 14 | 2019 | 312 | 2.310 |
Why?
| Materials Testing | 34 | 2019 | 350 | 2.260 |
Why?
| Cartilage | 12 | 2018 | 196 | 2.100 |
Why?
| Transforming Growth Factor beta1 | 12 | 2020 | 169 | 2.010 |
Why?
| Cell Communication | 10 | 2016 | 287 | 2.010 |
Why?
| Cell Adhesion | 21 | 2014 | 454 | 1.970 |
Why?
| Cell Movement | 9 | 2015 | 929 | 1.910 |
Why?
| Proteins | 7 | 2023 | 953 | 1.900 |
Why?
| Matrix Metalloproteinases | 9 | 2017 | 91 | 1.870 |
Why?
| Photochemical Processes | 12 | 2018 | 101 | 1.870 |
Why?
| Cartilage, Articular | 8 | 2021 | 315 | 1.780 |
Why?
| Collagen | 14 | 2021 | 436 | 1.750 |
Why?
| Actins | 16 | 2022 | 409 | 1.730 |
Why?
| Intestines | 4 | 2023 | 338 | 1.700 |
Why?
| Insulin-Secreting Cells | 7 | 2014 | 333 | 1.690 |
Why?
| Microscopy | 2 | 2023 | 132 | 1.610 |
Why?
| Esters | 4 | 2020 | 60 | 1.590 |
Why?
| Azides | 5 | 2022 | 47 | 1.500 |
Why?
| Melanoma | 4 | 2021 | 709 | 1.480 |
Why?
| Paracrine Communication | 3 | 2020 | 60 | 1.390 |
Why?
| Cells, Immobilized | 7 | 2018 | 23 | 1.360 |
Why?
| Cadherins | 3 | 2022 | 190 | 1.310 |
Why?
| Islets of Langerhans | 7 | 2010 | 749 | 1.300 |
Why?
| Fibrosis | 7 | 2022 | 497 | 1.270 |
Why?
| Extracellular Matrix Proteins | 4 | 2013 | 133 | 1.250 |
Why?
| Anhydrides | 8 | 2010 | 18 | 1.250 |
Why?
| Coated Materials, Biocompatible | 5 | 2011 | 60 | 1.250 |
Why?
| Molecular Structure | 19 | 2018 | 463 | 1.250 |
Why?
| Signal Transduction | 15 | 2022 | 4902 | 1.240 |
Why?
| Polymerization | 7 | 2018 | 130 | 1.240 |
Why?
| Fibroblast Growth Factor 2 | 5 | 2008 | 91 | 1.230 |
Why?
| Indoles | 4 | 2017 | 318 | 1.220 |
Why?
| Mice | 45 | 2023 | 15888 | 1.200 |
Why?
| Spheroids, Cellular | 3 | 2017 | 57 | 1.190 |
Why?
| Elastic Modulus | 8 | 2017 | 116 | 1.180 |
Why?
| Capsules | 7 | 2019 | 37 | 1.170 |
Why?
| Serum | 3 | 2022 | 65 | 1.160 |
Why?
| Adaptor Proteins, Signal Transducing | 6 | 2021 | 408 | 1.150 |
Why?
| Cell Proliferation | 20 | 2022 | 2328 | 1.140 |
Why?
| Humans | 102 | 2023 | 122796 | 1.130 |
Why?
| Gels | 8 | 2008 | 90 | 1.120 |
Why?
| Sulfides | 4 | 2022 | 102 | 1.100 |
Why?
| Phenotype | 11 | 2023 | 3070 | 1.100 |
Why?
| Gene Expression | 9 | 2022 | 1506 | 1.100 |
Why?
| Islets of Langerhans Transplantation | 4 | 2010 | 68 | 1.090 |
Why?
| Allyl Compounds | 3 | 2022 | 18 | 1.090 |
Why?
| Acrylates | 11 | 2012 | 45 | 1.080 |
Why?
| Sus scrofa | 6 | 2020 | 57 | 1.060 |
Why?
| Myoblasts | 4 | 2021 | 76 | 1.060 |
Why?
| Transforming Growth Factor beta | 5 | 2014 | 468 | 1.050 |
Why?
| Heparin | 6 | 2010 | 240 | 1.040 |
Why?
| Mechanical Phenomena | 3 | 2019 | 84 | 1.010 |
Why?
| Staphylococcus epidermidis | 3 | 2010 | 70 | 1.000 |
Why?
| Vancomycin | 3 | 2010 | 81 | 0.970 |
Why?
| Heart Valve Diseases | 3 | 2014 | 137 | 0.970 |
Why?
| Bone Regeneration | 4 | 2020 | 21 | 0.970 |
Why?
| Viscosity | 4 | 2020 | 90 | 0.960 |
Why?
| Collagenases | 3 | 2015 | 22 | 0.960 |
Why?
| Acrylic Resins | 2 | 2021 | 41 | 0.950 |
Why?
| Regenerative Medicine | 2 | 2017 | 46 | 0.940 |
Why?
| Kinetics | 20 | 2020 | 1658 | 0.930 |
Why?
| Polyesters | 6 | 2009 | 66 | 0.930 |
Why?
| Norbornanes | 3 | 2013 | 13 | 0.920 |
Why?
| Bone Substitutes | 5 | 2019 | 28 | 0.910 |
Why?
| Delayed-Action Preparations | 10 | 2018 | 162 | 0.910 |
Why?
| Sulfonamides | 3 | 2017 | 455 | 0.900 |
Why?
| Alkynes | 5 | 2022 | 56 | 0.860 |
Why?
| Podosomes | 1 | 2021 | 3 | 0.840 |
Why?
| Genes, X-Linked | 1 | 2022 | 19 | 0.840 |
Why?
| Peptide Fragments | 4 | 2013 | 715 | 0.840 |
Why?
| X Chromosome Inactivation | 1 | 2022 | 23 | 0.840 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2022 | 38 | 0.840 |
Why?
| Rats | 26 | 2022 | 5426 | 0.830 |
Why?
| Cell Line | 13 | 2017 | 2785 | 0.830 |
Why?
| Stress, Mechanical | 9 | 2021 | 440 | 0.820 |
Why?
| Elastomers | 1 | 2021 | 26 | 0.810 |
Why?
| NIH 3T3 Cells | 11 | 2020 | 141 | 0.800 |
Why?
| Dexamethasone | 4 | 2013 | 323 | 0.790 |
Why?
| Chondrogenesis | 4 | 2011 | 85 | 0.790 |
Why?
| Skull | 5 | 2012 | 145 | 0.790 |
Why?
| Intestinal Mucosa | 5 | 2023 | 543 | 0.790 |
Why?
| Cattle | 18 | 2018 | 994 | 0.780 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2021 | 1181 | 0.780 |
Why?
| Mechanoreceptors | 1 | 2020 | 14 | 0.770 |
Why?
| Bone and Bones | 5 | 2019 | 296 | 0.760 |
Why?
| Calcium Signaling | 2 | 2020 | 232 | 0.760 |
Why?
| Myocytes, Cardiac | 5 | 2020 | 483 | 0.760 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2021 | 98 | 0.740 |
Why?
| Inflammation Mediators | 2 | 2020 | 515 | 0.740 |
Why?
| Rheology | 6 | 2020 | 94 | 0.730 |
Why?
| Regeneration | 4 | 2016 | 171 | 0.730 |
Why?
| Fluorescent Dyes | 5 | 2015 | 319 | 0.720 |
Why?
| Tumor Microenvironment | 3 | 2021 | 457 | 0.720 |
Why?
| Phosphates | 3 | 2012 | 170 | 0.720 |
Why?
| Drug Carriers | 7 | 2017 | 118 | 0.720 |
Why?
| Anthracenes | 1 | 2019 | 29 | 0.700 |
Why?
| Methacrylates | 6 | 2012 | 111 | 0.700 |
Why?
| Proteoglycans | 3 | 2013 | 111 | 0.680 |
Why?
| Osteoporosis | 1 | 2022 | 234 | 0.680 |
Why?
| Azo Compounds | 2 | 2018 | 26 | 0.680 |
Why?
| Biophysics | 1 | 2019 | 74 | 0.680 |
Why?
| Models, Biological | 8 | 2015 | 1756 | 0.680 |
Why?
| Cyclooctanes | 1 | 2018 | 5 | 0.670 |
Why?
| Viscoelastic Substances | 2 | 2020 | 9 | 0.670 |
Why?
| Aza Compounds | 1 | 2018 | 12 | 0.670 |
Why?
| Lactic Acid | 6 | 2016 | 283 | 0.660 |
Why?
| Models, Chemical | 7 | 2009 | 273 | 0.660 |
Why?
| Surface Properties | 12 | 2012 | 402 | 0.660 |
Why?
| Transcriptome | 5 | 2022 | 774 | 0.650 |
Why?
| Peptides, Cyclic | 2 | 2010 | 260 | 0.650 |
Why?
| Pulmonary Alveoli | 3 | 2017 | 395 | 0.640 |
Why?
| Precision Medicine | 2 | 2022 | 371 | 0.640 |
Why?
| Fibronectins | 6 | 2012 | 115 | 0.630 |
Why?
| Proto-Oncogene Proteins B-raf | 2 | 2021 | 204 | 0.630 |
Why?
| Alkaline Phosphatase | 8 | 2016 | 161 | 0.630 |
Why?
| Hyaluronic Acid | 5 | 2018 | 203 | 0.620 |
Why?
| Molecular Probes | 1 | 2017 | 31 | 0.620 |
Why?
| Insulin | 9 | 2014 | 2180 | 0.610 |
Why?
| Nanoparticles | 3 | 2018 | 329 | 0.610 |
Why?
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 162 | 0.590 |
Why?
| Cell Line, Tumor | 10 | 2017 | 2904 | 0.590 |
Why?
| Antigens | 3 | 2013 | 337 | 0.590 |
Why?
| Biopolymers | 3 | 2022 | 28 | 0.590 |
Why?
| Macromolecular Substances | 3 | 2017 | 207 | 0.570 |
Why?
| Lipase | 2 | 2007 | 70 | 0.570 |
Why?
| DNA | 6 | 2006 | 1401 | 0.570 |
Why?
| Cell Self Renewal | 1 | 2016 | 51 | 0.560 |
Why?
| Coculture Techniques | 6 | 2019 | 213 | 0.560 |
Why?
| Apoptosis | 10 | 2017 | 2532 | 0.550 |
Why?
| Myocardium | 4 | 2023 | 982 | 0.550 |
Why?
| Amino Acid Sequence | 7 | 2015 | 2123 | 0.550 |
Why?
| Muscle, Smooth | 4 | 2009 | 159 | 0.550 |
Why?
| Microspheres | 2 | 2015 | 132 | 0.540 |
Why?
| Gene Expression Regulation | 8 | 2022 | 2491 | 0.540 |
Why?
| Microarray Analysis | 1 | 2015 | 124 | 0.530 |
Why?
| Macrophages | 2 | 2020 | 1334 | 0.520 |
Why?
| Bone Morphogenetic Protein 2 | 2 | 2012 | 94 | 0.510 |
Why?
| Niacinamide | 1 | 2015 | 72 | 0.510 |
Why?
| Phenylurea Compounds | 1 | 2015 | 84 | 0.500 |
Why?
| Rats, Sprague-Dawley | 11 | 2022 | 2501 | 0.500 |
Why?
| Solubility | 5 | 2020 | 240 | 0.500 |
Why?
| 3T3 Cells | 4 | 2012 | 141 | 0.490 |
Why?
| Immobilized Proteins | 1 | 2014 | 13 | 0.490 |
Why?
| Staphylococcal Infections | 2 | 2009 | 348 | 0.490 |
Why?
| Factor XIIIa | 1 | 2013 | 5 | 0.480 |
Why?
| Immunohistochemistry | 7 | 2022 | 1727 | 0.480 |
Why?
| Microscopy, Confocal | 4 | 2012 | 319 | 0.480 |
Why?
| Cell Engineering | 1 | 2013 | 7 | 0.480 |
Why?
| Protein Kinase Inhibitors | 2 | 2021 | 833 | 0.480 |
Why?
| Biochemistry | 1 | 2014 | 40 | 0.470 |
Why?
| Antibodies | 2 | 2006 | 400 | 0.470 |
Why?
| Prostheses and Implants | 5 | 2009 | 145 | 0.470 |
Why?
| Serum Albumin, Bovine | 2 | 2018 | 69 | 0.470 |
Why?
| Microfluidics | 3 | 2010 | 52 | 0.460 |
Why?
| Epithelial Cells | 4 | 2022 | 995 | 0.460 |
Why?
| Biomarkers | 5 | 2022 | 3662 | 0.460 |
Why?
| beta Catenin | 1 | 2015 | 223 | 0.450 |
Why?
| Compressive Strength | 5 | 2021 | 69 | 0.450 |
Why?
| Orthopedics | 4 | 2007 | 163 | 0.440 |
Why?
| Polystyrenes | 5 | 2014 | 35 | 0.440 |
Why?
| Nanocapsules | 1 | 2012 | 8 | 0.440 |
Why?
| Cytokines | 1 | 2020 | 1928 | 0.430 |
Why?
| Stem Cells | 3 | 2022 | 576 | 0.430 |
Why?
| Leukocyte Elastase | 2 | 2009 | 84 | 0.430 |
Why?
| Microfluidic Analytical Techniques | 4 | 2018 | 74 | 0.430 |
Why?
| Molecular Weight | 5 | 2014 | 346 | 0.420 |
Why?
| Disease Progression | 3 | 2021 | 2546 | 0.420 |
Why?
| Time Factors | 14 | 2011 | 6682 | 0.420 |
Why?
| Biomechanical Phenomena | 6 | 2017 | 705 | 0.410 |
Why?
| Embryonic Stem Cells | 2 | 2014 | 111 | 0.400 |
Why?
| Cell Transformation, Neoplastic | 1 | 2013 | 320 | 0.400 |
Why?
| Printing, Three-Dimensional | 2 | 2022 | 67 | 0.400 |
Why?
| Awards and Prizes | 1 | 2012 | 57 | 0.400 |
Why?
| Nerve Net | 1 | 2014 | 249 | 0.400 |
Why?
| Gelatin | 2 | 2017 | 36 | 0.400 |
Why?
| TRPV Cation Channels | 2 | 2022 | 35 | 0.400 |
Why?
| Culture Media | 4 | 2014 | 165 | 0.400 |
Why?
| MAP Kinase Signaling System | 3 | 2021 | 304 | 0.400 |
Why?
| Titanium | 2 | 2010 | 64 | 0.390 |
Why?
| Endothelial Cells | 2 | 2014 | 749 | 0.390 |
Why?
| Metalloporphyrins | 1 | 2011 | 109 | 0.390 |
Why?
| Superoxides | 1 | 2011 | 225 | 0.380 |
Why?
| Collagen Type I | 4 | 2020 | 113 | 0.380 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 1003 | 0.380 |
Why?
| Organ Culture Techniques | 1 | 2010 | 152 | 0.380 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2010 | 19 | 0.370 |
Why?
| Prosthesis-Related Infections | 2 | 2009 | 74 | 0.370 |
Why?
| Anti-Bacterial Agents | 2 | 2010 | 1562 | 0.370 |
Why?
| Fibrosarcoma | 1 | 2009 | 20 | 0.370 |
Why?
| Phosphinic Acids | 1 | 2009 | 9 | 0.360 |
Why?
| fas Receptor | 1 | 2010 | 95 | 0.360 |
Why?
| Cardiomyopathies | 1 | 2013 | 308 | 0.360 |
Why?
| Pravastatin | 1 | 2009 | 33 | 0.360 |
Why?
| Magnetic Resonance Spectroscopy | 7 | 2009 | 513 | 0.360 |
Why?
| Heart Defects, Congenital | 2 | 2014 | 721 | 0.360 |
Why?
| Equipment Design | 4 | 2017 | 533 | 0.360 |
Why?
| Parathyroid Hormone | 2 | 2020 | 99 | 0.350 |
Why?
| Polyvinyl Alcohol | 4 | 2002 | 14 | 0.350 |
Why?
| Phosphoproteins | 3 | 2017 | 332 | 0.350 |
Why?
| Chemokine CCL2 | 1 | 2009 | 126 | 0.350 |
Why?
| Plasmids | 4 | 2007 | 358 | 0.350 |
Why?
| Transcription Factors | 4 | 2021 | 1616 | 0.350 |
Why?
| Superoxide Dismutase | 1 | 2011 | 345 | 0.350 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2009 | 39 | 0.350 |
Why?
| Recombinant Proteins | 5 | 2012 | 1318 | 0.350 |
Why?
| Bioprinting | 2 | 2022 | 20 | 0.340 |
Why?
| Cycloaddition Reaction | 5 | 2021 | 24 | 0.340 |
Why?
| Enzymes | 1 | 2009 | 66 | 0.340 |
Why?
| Heart Valve Prosthesis | 3 | 2005 | 126 | 0.340 |
Why?
| Molecular Sequence Data | 4 | 2015 | 2933 | 0.340 |
Why?
| Dendritic Cells | 1 | 2012 | 445 | 0.330 |
Why?
| Trans-Activators | 3 | 2021 | 382 | 0.330 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2009 | 105 | 0.330 |
Why?
| Protein Engineering | 2 | 2008 | 106 | 0.330 |
Why?
| T-Lymphocytes | 3 | 2012 | 1814 | 0.330 |
Why?
| Hemodynamics | 1 | 2013 | 1036 | 0.330 |
Why?
| Protein Binding | 6 | 2010 | 2010 | 0.330 |
Why?
| Polyhydroxyethyl Methacrylate | 3 | 2007 | 10 | 0.330 |
Why?
| In Vitro Techniques | 5 | 2014 | 1130 | 0.320 |
Why?
| Neoplasm Invasiveness | 1 | 2009 | 472 | 0.320 |
Why?
| Glucose Oxidase | 4 | 2011 | 19 | 0.320 |
Why?
| Smad Proteins | 1 | 2008 | 38 | 0.320 |
Why?
| Transfection | 5 | 2011 | 909 | 0.320 |
Why?
| Biofilms | 1 | 2010 | 236 | 0.320 |
Why?
| Microscopy, Electron, Scanning | 7 | 2012 | 201 | 0.320 |
Why?
| Bone Cements | 2 | 2010 | 39 | 0.310 |
Why?
| Glucocorticoids | 1 | 2012 | 554 | 0.310 |
Why?
| Anoikis | 1 | 2007 | 35 | 0.300 |
Why?
| Collagen Type II | 4 | 2009 | 48 | 0.300 |
Why?
| Glucose | 6 | 2014 | 968 | 0.300 |
Why?
| Aorta | 1 | 2009 | 368 | 0.300 |
Why?
| Shear Strength | 2 | 2020 | 58 | 0.300 |
Why?
| Students | 1 | 2012 | 529 | 0.290 |
Why?
| Ultraviolet Rays | 5 | 2009 | 413 | 0.290 |
Why?
| Growth Substances | 3 | 2003 | 140 | 0.290 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2006 | 48 | 0.280 |
Why?
| Adsorption | 4 | 2012 | 130 | 0.280 |
Why?
| Cell Shape | 3 | 2022 | 55 | 0.280 |
Why?
| Nerve Tissue | 1 | 2005 | 5 | 0.280 |
Why?
| Biology | 2 | 2017 | 87 | 0.270 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2014 | 52 | 0.270 |
Why?
| Cell Nucleus | 2 | 2020 | 598 | 0.270 |
Why?
| Extracellular Fluid | 1 | 2005 | 32 | 0.270 |
Why?
| Porosity | 2 | 2019 | 88 | 0.270 |
Why?
| Biodegradation, Environmental | 6 | 2003 | 82 | 0.270 |
Why?
| Staining and Labeling | 3 | 2015 | 159 | 0.260 |
Why?
| Mammals | 2 | 2022 | 257 | 0.260 |
Why?
| Cell Separation | 2 | 2018 | 303 | 0.260 |
Why?
| Temperature | 4 | 2013 | 631 | 0.260 |
Why?
| Otorhinolaryngologic Diseases | 1 | 2005 | 17 | 0.260 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 410 | 0.260 |
Why?
| Bioprosthesis | 1 | 2005 | 37 | 0.260 |
Why?
| Microscopy, Atomic Force | 3 | 2017 | 119 | 0.260 |
Why?
| Organophosphates | 1 | 2005 | 94 | 0.250 |
Why?
| Polyanhydrides | 1 | 2004 | 2 | 0.250 |
Why?
| Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 839 | 0.250 |
Why?
| Guided Tissue Regeneration | 1 | 2004 | 13 | 0.250 |
Why?
| Primary Cell Culture | 3 | 2016 | 156 | 0.250 |
Why?
| MicroRNAs | 1 | 2011 | 661 | 0.250 |
Why?
| Cell Membrane | 3 | 2013 | 741 | 0.240 |
Why?
| Diffusion | 4 | 2009 | 127 | 0.240 |
Why?
| Spectroscopy, Fourier Transform Infrared | 4 | 2010 | 88 | 0.240 |
Why?
| Ultrasonography | 1 | 2008 | 740 | 0.240 |
Why?
| Cell Transplantation | 1 | 2003 | 39 | 0.240 |
Why?
| Nitrites | 1 | 2004 | 81 | 0.240 |
Why?
| Chemistry, Pharmaceutical | 2 | 2017 | 108 | 0.230 |
Why?
| Cell Cycle | 2 | 2019 | 584 | 0.230 |
Why?
| Aldehydes | 2 | 2014 | 155 | 0.230 |
Why?
| Drug Design | 3 | 2012 | 163 | 0.230 |
Why?
| Reproducibility of Results | 3 | 2020 | 2977 | 0.230 |
Why?
| Endoglin | 2 | 2016 | 21 | 0.230 |
Why?
| Microscopy, Fluorescence | 3 | 2012 | 418 | 0.230 |
Why?
| Butadienes | 1 | 2003 | 34 | 0.230 |
Why?
| Annexin A2 | 1 | 2022 | 12 | 0.220 |
Why?
| Laminin | 3 | 2008 | 67 | 0.220 |
Why?
| Axons | 2 | 2014 | 185 | 0.220 |
Why?
| Weight-Bearing | 1 | 2004 | 181 | 0.220 |
Why?
| Male | 16 | 2022 | 59639 | 0.220 |
Why?
| Neurons | 3 | 2010 | 1345 | 0.220 |
Why?
| Calcification, Physiologic | 1 | 2002 | 33 | 0.220 |
Why?
| Calcium | 3 | 2014 | 1244 | 0.220 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 25 | 0.220 |
Why?
| Particle Size | 4 | 2012 | 344 | 0.220 |
Why?
| Mice, Inbred BALB C | 3 | 2010 | 1245 | 0.220 |
Why?
| Dose-Response Relationship, Drug | 4 | 2012 | 1981 | 0.210 |
Why?
| Muscle Contraction | 2 | 2019 | 415 | 0.210 |
Why?
| Receptors, Cell Surface | 3 | 2008 | 368 | 0.210 |
Why?
| Interstitial Cells of Cajal | 2 | 2019 | 4 | 0.210 |
Why?
| Morphogenesis | 1 | 2023 | 176 | 0.210 |
Why?
| Ovariectomy | 1 | 2022 | 125 | 0.210 |
Why?
| Sex Factors | 3 | 2022 | 1860 | 0.210 |
Why?
| Gene Expression Profiling | 2 | 2022 | 1625 | 0.200 |
Why?
| Mice, Nude | 4 | 2015 | 668 | 0.200 |
Why?
| Robotics | 1 | 2023 | 87 | 0.200 |
Why?
| Osteopontin | 3 | 2006 | 39 | 0.200 |
Why?
| Organogenesis | 1 | 2022 | 57 | 0.200 |
Why?
| Isoelectric Point | 1 | 2021 | 23 | 0.200 |
Why?
| Drug Compounding | 4 | 2005 | 92 | 0.200 |
Why?
| Vinculin | 2 | 2013 | 11 | 0.200 |
Why?
| Temporomandibular Joint | 1 | 2001 | 12 | 0.200 |
Why?
| Focal Adhesions | 2 | 2015 | 44 | 0.200 |
Why?
| Glycosaminoglycans | 4 | 2008 | 81 | 0.200 |
Why?
| Sialoglycoproteins | 3 | 2006 | 162 | 0.200 |
Why?
| Isoproterenol | 1 | 2021 | 127 | 0.190 |
Why?
| Base Sequence | 4 | 2012 | 2186 | 0.190 |
Why?
| Membrane Proteins | 2 | 2020 | 1093 | 0.190 |
Why?
| Secretory Pathway | 1 | 2020 | 7 | 0.190 |
Why?
| THP-1 Cells | 1 | 2020 | 24 | 0.190 |
Why?
| Muramidase | 2 | 2012 | 73 | 0.190 |
Why?
| Tricarboxylic Acids | 1 | 2000 | 11 | 0.190 |
Why?
| Bacterial Adhesion | 2 | 2012 | 79 | 0.190 |
Why?
| Chromatography, Gel | 3 | 2007 | 129 | 0.190 |
Why?
| Receptors, Adrenergic, beta | 1 | 2021 | 146 | 0.190 |
Why?
| Wound Healing | 4 | 2022 | 279 | 0.190 |
Why?
| Hydroxamic Acids | 1 | 2020 | 80 | 0.190 |
Why?
| Fluoresceins | 2 | 2012 | 47 | 0.180 |
Why?
| Muscle Fibers, Skeletal | 1 | 2021 | 197 | 0.180 |
Why?
| Hexanes | 1 | 1999 | 3 | 0.180 |
Why?
| Matrix Metalloproteinase 9 | 2 | 2017 | 131 | 0.180 |
Why?
| Photosensitizing Agents | 1 | 2000 | 31 | 0.180 |
Why?
| Acetylation | 1 | 2020 | 227 | 0.180 |
Why?
| Dicarboxylic Acids | 1 | 1999 | 6 | 0.180 |
Why?
| Adipogenesis | 2 | 2011 | 49 | 0.180 |
Why?
| Cardiomegaly | 1 | 2020 | 168 | 0.180 |
Why?
| DNA Primers | 3 | 2012 | 540 | 0.180 |
Why?
| Ligands | 2 | 2014 | 582 | 0.180 |
Why?
| Boronic Acids | 1 | 2019 | 43 | 0.170 |
Why?
| Triazoles | 1 | 2020 | 135 | 0.170 |
Why?
| Antibodies, Immobilized | 1 | 2018 | 1 | 0.170 |
Why?
| Isomerism | 2 | 2018 | 43 | 0.170 |
Why?
| Bone Diseases | 1 | 2019 | 60 | 0.170 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2020 | 202 | 0.170 |
Why?
| Histone Deacetylases | 1 | 2020 | 202 | 0.170 |
Why?
| Bioengineering | 1 | 2018 | 13 | 0.170 |
Why?
| Receptors, Fibroblast Growth Factor | 2 | 2010 | 64 | 0.170 |
Why?
| Phenylacetates | 1 | 2018 | 10 | 0.160 |
Why?
| Sex Characteristics | 2 | 2022 | 690 | 0.160 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 433 | 0.160 |
Why?
| Gold | 1 | 2019 | 106 | 0.160 |
Why?
| Jurkat Cells | 2 | 2010 | 139 | 0.160 |
Why?
| Absorbable Implants | 2 | 2009 | 35 | 0.160 |
Why?
| Metal Nanoparticles | 1 | 2019 | 74 | 0.160 |
Why?
| Bacteriophage T4 | 1 | 2018 | 17 | 0.160 |
Why?
| Neoplastic Cells, Circulating | 1 | 2018 | 64 | 0.160 |
Why?
| DNA Ligases | 1 | 2018 | 16 | 0.160 |
Why?
| Equipment Failure Analysis | 2 | 2017 | 142 | 0.160 |
Why?
| beta-Cyclodextrins | 1 | 2018 | 32 | 0.160 |
Why?
| Female | 12 | 2022 | 63629 | 0.160 |
Why?
| Dendrimers | 1 | 2017 | 13 | 0.160 |
Why?
| Chemotaxis | 2 | 2009 | 141 | 0.160 |
Why?
| Absorption | 2 | 2009 | 56 | 0.160 |
Why?
| A549 Cells | 1 | 2017 | 56 | 0.160 |
Why?
| Animals, Newborn | 3 | 2006 | 825 | 0.160 |
Why?
| Integrins | 2 | 2009 | 83 | 0.150 |
Why?
| Hydrolysis | 4 | 2007 | 189 | 0.150 |
Why?
| Heart Diseases | 1 | 2021 | 358 | 0.150 |
Why?
| Substrate Specificity | 2 | 2009 | 375 | 0.150 |
Why?
| Biomedical Engineering | 4 | 2001 | 23 | 0.150 |
Why?
| Nanotubes, Carbon | 1 | 2017 | 45 | 0.150 |
Why?
| Biomimetics | 1 | 2017 | 41 | 0.150 |
Why?
| Antigens, Neoplasm | 1 | 2018 | 228 | 0.150 |
Why?
| Heart | 1 | 2021 | 649 | 0.150 |
Why?
| Periodicals as Topic | 2 | 2017 | 239 | 0.150 |
Why?
| Enzyme Stability | 2 | 2018 | 77 | 0.150 |
Why?
| Rubber | 1 | 1996 | 8 | 0.150 |
Why?
| Culture Media, Serum-Free | 2 | 2007 | 41 | 0.150 |
Why?
| Elastin | 2 | 2008 | 78 | 0.140 |
Why?
| DNA, Neoplasm | 1 | 2017 | 155 | 0.140 |
Why?
| Tensile Strength | 4 | 2003 | 100 | 0.140 |
Why?
| Cell Division | 4 | 2004 | 788 | 0.140 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2017 | 190 | 0.140 |
Why?
| Hydrogen-Ion Concentration | 3 | 2008 | 547 | 0.140 |
Why?
| Maleimides | 2 | 2013 | 24 | 0.140 |
Why?
| Epigenesis, Genetic | 1 | 2020 | 551 | 0.140 |
Why?
| Furans | 2 | 2013 | 24 | 0.140 |
Why?
| Nanomedicine | 1 | 2016 | 28 | 0.140 |
Why?
| Hot Temperature | 1 | 2018 | 345 | 0.140 |
Why?
| Viral Proteins | 1 | 2018 | 300 | 0.140 |
Why?
| Stromal Cells | 1 | 2015 | 103 | 0.130 |
Why?
| Composite Resins | 1 | 1996 | 104 | 0.130 |
Why?
| Histones | 1 | 2020 | 562 | 0.130 |
Why?
| Structure-Activity Relationship | 2 | 2009 | 536 | 0.130 |
Why?
| Medicine | 1 | 2017 | 112 | 0.130 |
Why?
| Disease Models, Animal | 2 | 2022 | 3799 | 0.130 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 432 | 0.130 |
Why?
| Computational Biology | 2 | 2022 | 601 | 0.130 |
Why?
| Models, Theoretical | 4 | 2007 | 574 | 0.130 |
Why?
| Ethylene Glycols | 3 | 2000 | 15 | 0.130 |
Why?
| Electrophoresis, Agar Gel | 2 | 2004 | 25 | 0.130 |
Why?
| Cell-Matrix Junctions | 1 | 2014 | 2 | 0.120 |
Why?
| Cytostatic Agents | 1 | 2014 | 8 | 0.120 |
Why?
| Streptavidin | 1 | 2014 | 17 | 0.120 |
Why?
| Acyltransferases | 1 | 2014 | 53 | 0.120 |
Why?
| Glass | 1 | 2014 | 45 | 0.120 |
Why?
| Integrin beta1 | 1 | 2013 | 20 | 0.120 |
Why?
| Benzaldehydes | 1 | 2013 | 8 | 0.120 |
Why?
| Basal Metabolism | 1 | 2014 | 50 | 0.120 |
Why?
| Molecular Mimicry | 1 | 2013 | 40 | 0.120 |
Why?
| CD146 Antigen | 1 | 2013 | 42 | 0.120 |
Why?
| Stage-Specific Embryonic Antigens | 1 | 2013 | 3 | 0.120 |
Why?
| Cyclization | 2 | 2011 | 24 | 0.120 |
Why?
| Benzoquinones | 1 | 2014 | 45 | 0.120 |
Why?
| Biophysical Phenomena | 1 | 2013 | 65 | 0.120 |
Why?
| Coloring Agents | 1 | 2013 | 75 | 0.120 |
Why?
| Fluorescence Resonance Energy Transfer | 2 | 2019 | 188 | 0.120 |
Why?
| Muscle Cells | 1 | 2013 | 41 | 0.120 |
Why?
| Cryoultramicrotomy | 1 | 2013 | 3 | 0.120 |
Why?
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 59 | 0.120 |
Why?
| Decanoic Acids | 2 | 2005 | 10 | 0.110 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2014 | 198 | 0.110 |
Why?
| Gelatin Sponge, Absorbable | 1 | 2012 | 5 | 0.110 |
Why?
| Developmental Biology | 1 | 2012 | 18 | 0.110 |
Why?
| Sulfhydryl Reagents | 1 | 2012 | 11 | 0.110 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2013 | 128 | 0.110 |
Why?
| Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 44 | 0.110 |
Why?
| Ethers | 1 | 2012 | 17 | 0.110 |
Why?
| Connective Tissue Growth Factor | 1 | 2012 | 22 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.110 |
Why?
| Biofouling | 1 | 2012 | 7 | 0.110 |
Why?
| Wnt Proteins | 1 | 2013 | 144 | 0.110 |
Why?
| Systems Biology | 1 | 2012 | 59 | 0.110 |
Why?
| Fracture Healing | 1 | 2012 | 74 | 0.110 |
Why?
| Drug Resistance, Neoplasm | 1 | 2017 | 673 | 0.110 |
Why?
| Free Radicals | 1 | 2012 | 100 | 0.110 |
Why?
| Crystallization | 2 | 2009 | 148 | 0.100 |
Why?
| Bone Transplantation | 1 | 2012 | 100 | 0.100 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 358 | 0.100 |
Why?
| Receptor, EphA5 | 1 | 2011 | 1 | 0.100 |
Why?
| Ephrin-A5 | 1 | 2011 | 3 | 0.100 |
Why?
| China | 1 | 2012 | 223 | 0.100 |
Why?
| Endoplasmic Reticulum | 1 | 2013 | 250 | 0.100 |
Why?
| Thermodynamics | 1 | 2013 | 391 | 0.100 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2011 | 35 | 0.100 |
Why?
| Half-Life | 1 | 2011 | 147 | 0.100 |
Why?
| Biological Availability | 1 | 2011 | 129 | 0.100 |
Why?
| Homeostasis | 1 | 2014 | 596 | 0.100 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 373 | 0.100 |
Why?
| Surface Plasmon Resonance | 1 | 2011 | 85 | 0.100 |
Why?
| Heparin Lyase | 1 | 2010 | 4 | 0.100 |
Why?
| Cell Physiological Phenomena | 1 | 2010 | 23 | 0.100 |
Why?
| Blotting, Western | 1 | 2013 | 1225 | 0.100 |
Why?
| Carbohydrate Sequence | 1 | 2010 | 23 | 0.100 |
Why?
| Ascorbic Acid | 1 | 2011 | 116 | 0.100 |
Why?
| Polymethyl Methacrylate | 1 | 2010 | 20 | 0.100 |
Why?
| Flow Cytometry | 2 | 2011 | 1128 | 0.100 |
Why?
| Analysis of Variance | 1 | 2013 | 1329 | 0.090 |
Why?
| Copper | 1 | 2011 | 101 | 0.090 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 462 | 0.090 |
Why?
| Mice, Inbred NOD | 1 | 2012 | 588 | 0.090 |
Why?
| Foreskin | 1 | 2009 | 8 | 0.090 |
Why?
| Enzyme Assays | 1 | 2009 | 24 | 0.090 |
Why?
| Interleukin-10 | 1 | 2012 | 314 | 0.090 |
Why?
| Polymethacrylic Acids | 2 | 2003 | 61 | 0.090 |
Why?
| Decorin | 1 | 2009 | 7 | 0.090 |
Why?
| Proto-Oncogene Proteins | 1 | 2013 | 646 | 0.090 |
Why?
| Biosensing Techniques | 1 | 2011 | 111 | 0.090 |
Why?
| Biochemical Phenomena | 1 | 2009 | 10 | 0.090 |
Why?
| Lithium | 1 | 2009 | 43 | 0.090 |
Why?
| Acrylamides | 1 | 2009 | 43 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 1859 | 0.090 |
Why?
| High-Throughput Screening Assays | 1 | 2010 | 126 | 0.090 |
Why?
| Adrenal Glands | 1 | 2009 | 75 | 0.090 |
Why?
| Cloning, Molecular | 1 | 2010 | 551 | 0.090 |
Why?
| Bone Morphogenetic Proteins | 2 | 2007 | 141 | 0.090 |
Why?
| Biotechnology | 1 | 2009 | 45 | 0.090 |
Why?
| Culture Techniques | 1 | 2008 | 81 | 0.090 |
Why?
| Cysteine | 1 | 2010 | 187 | 0.090 |
Why?
| Amino Acid Motifs | 1 | 2009 | 206 | 0.090 |
Why?
| Keratinocytes | 1 | 2010 | 238 | 0.080 |
Why?
| Computer Simulation | 2 | 2013 | 945 | 0.080 |
Why?
| X-Ray Diffraction | 2 | 2005 | 87 | 0.080 |
Why?
| Fibroblast Growth Factors | 1 | 2010 | 180 | 0.080 |
Why?
| Microchemistry | 1 | 2008 | 15 | 0.080 |
Why?
| Serum Albumin | 1 | 2009 | 151 | 0.080 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 5020 | 0.080 |
Why?
| Neoplasms | 1 | 2023 | 2235 | 0.080 |
Why?
| Probability | 1 | 2009 | 316 | 0.080 |
Why?
| Fibrin | 1 | 2008 | 63 | 0.080 |
Why?
| Ultrasonics | 1 | 2008 | 53 | 0.080 |
Why?
| Integrin alpha5beta1 | 1 | 2008 | 9 | 0.080 |
Why?
| Matrix Metalloproteinase 13 | 1 | 2008 | 25 | 0.080 |
Why?
| Microbial Sensitivity Tests | 1 | 2009 | 312 | 0.080 |
Why?
| Integrin alphaVbeta3 | 1 | 2008 | 25 | 0.080 |
Why?
| Surface-Active Agents | 1 | 2008 | 81 | 0.080 |
Why?
| Recombinant Fusion Proteins | 1 | 2011 | 661 | 0.080 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 2009 | 3388 | 0.080 |
Why?
| Lasers | 1 | 2008 | 123 | 0.080 |
Why?
| Surgical Wound Infection | 1 | 2010 | 251 | 0.080 |
Why?
| Lymphocyte Activation | 1 | 2012 | 1148 | 0.080 |
Why?
| Immunosuppressive Agents | 1 | 2012 | 687 | 0.080 |
Why?
| Drug Stability | 2 | 2005 | 157 | 0.080 |
Why?
| Aggrecans | 1 | 2007 | 14 | 0.080 |
Why?
| Heparan Sulfate Proteoglycans | 1 | 2007 | 22 | 0.080 |
Why?
| Mitogens | 1 | 2007 | 61 | 0.080 |
Why?
| Hepatocyte Growth Factor | 1 | 2007 | 32 | 0.070 |
Why?
| RNA, Small Interfering | 1 | 2009 | 581 | 0.070 |
Why?
| Calorimetry, Differential Scanning | 3 | 2005 | 37 | 0.070 |
Why?
| Bioreactors | 1 | 2006 | 45 | 0.070 |
Why?
| Antigen-Antibody Reactions | 1 | 2006 | 54 | 0.070 |
Why?
| Water | 1 | 2009 | 433 | 0.070 |
Why?
| Environment | 1 | 2008 | 357 | 0.070 |
Why?
| Griseofulvin | 1 | 2005 | 2 | 0.070 |
Why?
| Stem Cell Transplantation | 1 | 2007 | 155 | 0.070 |
Why?
| Tetrazolium Salts | 1 | 2005 | 20 | 0.070 |
Why?
| Lung Neoplasms | 1 | 2018 | 2216 | 0.070 |
Why?
| X-Ray Microtomography | 2 | 2019 | 74 | 0.070 |
Why?
| Calcium Phosphates | 1 | 2005 | 26 | 0.070 |
Why?
| Polymerase Chain Reaction | 1 | 2008 | 1021 | 0.070 |
Why?
| Nanotechnology | 1 | 2007 | 122 | 0.070 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1990 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2011 | 1855 | 0.070 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2007 | 306 | 0.070 |
Why?
| Glucagon | 1 | 2005 | 97 | 0.070 |
Why?
| Ear, External | 1 | 2005 | 26 | 0.070 |
Why?
| Nasal Septum | 1 | 2005 | 17 | 0.070 |
Why?
| Antigens, CD | 1 | 2008 | 506 | 0.070 |
Why?
| Facial Bones | 1 | 2005 | 39 | 0.060 |
Why?
| Thiazoles | 1 | 2005 | 125 | 0.060 |
Why?
| Enzyme Activation | 1 | 2007 | 864 | 0.060 |
Why?
| Nose | 1 | 2005 | 58 | 0.060 |
Why?
| Immunoblotting | 1 | 2005 | 318 | 0.060 |
Why?
| Cell Count | 1 | 2005 | 319 | 0.060 |
Why?
| Larynx | 1 | 2005 | 57 | 0.060 |
Why?
| Hexuronic Acids | 1 | 2004 | 30 | 0.060 |
Why?
| Stress Fibers | 1 | 2004 | 18 | 0.060 |
Why?
| Glucuronic Acid | 1 | 2004 | 33 | 0.060 |
Why?
| Sheep | 1 | 2007 | 769 | 0.060 |
Why?
| Cytoskeleton | 1 | 2005 | 183 | 0.060 |
Why?
| Alginates | 1 | 2004 | 51 | 0.060 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2005 | 213 | 0.060 |
Why?
| Cell Size | 1 | 2004 | 86 | 0.060 |
Why?
| Photography | 1 | 2004 | 96 | 0.060 |
Why?
| Muscle, Skeletal | 1 | 2013 | 1556 | 0.060 |
Why?
| Catalysis | 2 | 2017 | 295 | 0.060 |
Why?
| Surgical Flaps | 1 | 2005 | 119 | 0.060 |
Why?
| Immunity, Innate | 1 | 2009 | 762 | 0.060 |
Why?
| Gene Transfer Techniques | 1 | 2004 | 154 | 0.060 |
Why?
| Magnetic Phenomena | 1 | 2023 | 10 | 0.060 |
Why?
| Trachea | 1 | 2005 | 238 | 0.060 |
Why?
| Oxidation-Reduction | 3 | 2011 | 931 | 0.060 |
Why?
| Cystatin C | 1 | 2022 | 71 | 0.060 |
Why?
| Diabetes Mellitus | 1 | 2011 | 985 | 0.050 |
Why?
| Cellular Senescence | 1 | 2023 | 156 | 0.050 |
Why?
| Biomarkers, Pharmacological | 1 | 2022 | 29 | 0.050 |
Why?
| Somatomedins | 1 | 2002 | 27 | 0.050 |
Why?
| Subcutaneous Tissue | 1 | 2002 | 20 | 0.050 |
Why?
| Injections | 1 | 2002 | 171 | 0.050 |
Why?
| Technology, Pharmaceutical | 1 | 2002 | 19 | 0.050 |
Why?
| Paneth Cells | 1 | 2022 | 18 | 0.050 |
Why?
| Genetic Therapy | 1 | 2003 | 265 | 0.050 |
Why?
| Tissue Culture Techniques | 1 | 2022 | 69 | 0.050 |
Why?
| Infant, Newborn | 2 | 2010 | 5430 | 0.050 |
Why?
| Femur | 2 | 2019 | 201 | 0.050 |
Why?
| Cicatrix | 1 | 2022 | 54 | 0.050 |
Why?
| Chlorobenzenes | 1 | 2001 | 8 | 0.050 |
Why?
| Temporomandibular Joint Disorders | 1 | 2001 | 10 | 0.050 |
Why?
| Receptors, Notch | 1 | 2022 | 88 | 0.050 |
Why?
| Succinimides | 1 | 2001 | 17 | 0.050 |
Why?
| Chromosomes | 1 | 2021 | 88 | 0.050 |
Why?
| Polyglycolic Acid | 1 | 2001 | 40 | 0.050 |
Why?
| Nucleic Acid Conformation | 1 | 2004 | 674 | 0.050 |
Why?
| Adrenergic beta-Agonists | 1 | 2021 | 134 | 0.050 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 135 | 0.050 |
Why?
| Lung | 1 | 2013 | 3830 | 0.050 |
Why?
| Mathematical Computing | 1 | 2000 | 13 | 0.050 |
Why?
| Fumarates | 1 | 2019 | 12 | 0.050 |
Why?
| Polypropylenes | 1 | 2019 | 19 | 0.050 |
Why?
| Gonadal Steroid Hormones | 1 | 2021 | 123 | 0.050 |
Why?
| Ursidae | 1 | 2019 | 12 | 0.050 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2000 | 131 | 0.050 |
Why?
| Lipids | 1 | 2003 | 614 | 0.040 |
Why?
| Muscles | 1 | 2001 | 336 | 0.040 |
Why?
| Antibodies, Monoclonal | 1 | 2006 | 1306 | 0.040 |
Why?
| Mitochondria | 1 | 2005 | 809 | 0.040 |
Why?
| Intracellular Space | 1 | 2019 | 72 | 0.040 |
Why?
| Spectrophotometry, Infrared | 1 | 1999 | 54 | 0.040 |
Why?
| Models, Genetic | 1 | 2022 | 599 | 0.040 |
Why?
| Zebrafish | 1 | 2023 | 477 | 0.040 |
Why?
| Inflammation | 1 | 2009 | 2598 | 0.040 |
Why?
| Drug Liberation | 1 | 2018 | 23 | 0.040 |
Why?
| Fluorescein-5-isothiocyanate | 1 | 2018 | 38 | 0.040 |
Why?
| Protein Transport | 1 | 2019 | 418 | 0.040 |
Why?
| Prosthesis Implantation | 1 | 1999 | 148 | 0.040 |
Why?
| RNA, Messenger | 1 | 2004 | 2720 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2018 | 904 | 0.040 |
Why?
| Proteomics | 1 | 2022 | 890 | 0.040 |
Why?
| Ketanserin | 1 | 1996 | 12 | 0.040 |
Why?
| Quality Control | 1 | 1996 | 165 | 0.040 |
Why?
| Genotype | 1 | 2021 | 1943 | 0.030 |
Why?
| Cell Cycle Proteins | 1 | 2019 | 576 | 0.030 |
Why?
| Sclerosis | 1 | 2014 | 14 | 0.030 |
Why?
| Collagen Type III | 1 | 2014 | 21 | 0.030 |
Why?
| Receptors, Wnt | 1 | 2013 | 2 | 0.030 |
Why?
| Coatomer Protein | 1 | 2013 | 3 | 0.030 |
Why?
| ras GTPase-Activating Proteins | 1 | 2013 | 15 | 0.030 |
Why?
| Wnt-5a Protein | 1 | 2013 | 19 | 0.030 |
Why?
| Exocytosis | 1 | 2014 | 90 | 0.030 |
Why?
| Feasibility Studies | 1 | 2016 | 780 | 0.030 |
Why?
| Myosins | 1 | 2013 | 130 | 0.030 |
Why?
| Cell Polarity | 1 | 2013 | 130 | 0.030 |
Why?
| Multiprotein Complexes | 1 | 2013 | 152 | 0.030 |
Why?
| Platelet Aggregation Inhibitors | 1 | 1996 | 425 | 0.030 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 179 | 0.030 |
Why?
| Myocardial Infarction | 1 | 2019 | 1134 | 0.020 |
Why?
| Pilot Projects | 1 | 2016 | 1477 | 0.020 |
Why?
| Ear Cartilage | 1 | 2010 | 3 | 0.020 |
Why?
| Microtubules | 1 | 2013 | 247 | 0.020 |
Why?
| Algorithms | 1 | 1999 | 1593 | 0.020 |
Why?
| Skin | 2 | 2010 | 694 | 0.020 |
Why?
| Integrin beta4 | 1 | 2010 | 1 | 0.020 |
Why?
| Keratin-14 | 1 | 2010 | 14 | 0.020 |
Why?
| Enzymes, Immobilized | 1 | 2011 | 31 | 0.020 |
Why?
| Dermis | 1 | 2010 | 30 | 0.020 |
Why?
| Biomedical Research | 1 | 2017 | 630 | 0.020 |
Why?
| Pseudomonas aeruginosa | 1 | 2012 | 310 | 0.020 |
Why?
| Physical Phenomena | 1 | 2009 | 12 | 0.020 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2010 | 319 | 0.020 |
Why?
| Amino Acids | 1 | 2013 | 463 | 0.020 |
Why?
| Dimerization | 2 | 1999 | 184 | 0.020 |
Why?
| Cell Lineage | 1 | 2010 | 326 | 0.020 |
Why?
| Escherichia coli | 1 | 2012 | 767 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2007 | 87 | 0.020 |
Why?
| Buffers | 1 | 2007 | 56 | 0.020 |
Why?
| Nanocomposites | 1 | 2007 | 17 | 0.020 |
Why?
| Skull Fractures | 1 | 2007 | 30 | 0.020 |
Why?
| Protons | 1 | 2007 | 79 | 0.020 |
Why?
| Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.020 |
Why?
| Chemical Precipitation | 1 | 2005 | 38 | 0.020 |
Why?
| Powders | 1 | 2005 | 36 | 0.020 |
Why?
| Excipients | 1 | 2005 | 51 | 0.020 |
Why?
| Treatment Outcome | 1 | 2019 | 9692 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2007 | 402 | 0.020 |
Why?
| Solutions | 1 | 2004 | 154 | 0.020 |
Why?
| DNA Replication | 1 | 2004 | 214 | 0.010 |
Why?
| Models, Statistical | 1 | 2006 | 651 | 0.010 |
Why?
| Patella | 1 | 2000 | 25 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 2004 | 1188 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 1999 | 137 | 0.010 |
Why?
| Adhesiveness | 1 | 1996 | 19 | 0.010 |
Why?
| Freezing | 1 | 1996 | 85 | 0.010 |
Why?
| Mucins | 1 | 1996 | 64 | 0.010 |
Why?
|
|
Anseth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|